Αρχειοθήκη ιστολογίου

Τρίτη 27 Ιουνίου 2017

Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group

Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group

British Journal of Cancer 117, 8 (27 June 2017). doi:10.1038/bjc.2017.137

Authors: F Koinis, S Agelaki, V Karavassilis, N Kentepozidis, E Samantas, S Peroukidis, P Katsaounis, E Hartabilas, I I Varthalitis, I Messaritakis, G Fountzilas, V Georgoulias & A Kotsakis

2uguYau

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2qpYWds


from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sPlVQj
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader